Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 65351 - 65375 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Resveratrol	Investigational	MIR501	574503	upregulated	resveratrol results in increased expression of MIR501 mRNA	Xp11.23	A23975
Resveratrol	Investigational	MIR503	574506	upregulated	resveratrol results in increased expression of MIR503 mRNA	Xq26.3	A23973
Resveratrol	Investigational	MIR504	574507	upregulated	resveratrol results in increased expression of MIR504 mRNA	Xq26.3	A23973
Resveratrol	Investigational	MIR507	574512	upregulated	resveratrol results in increased expression of MIR507 mRNA	Xq27.3	A23973
Resveratrol	Investigational	MIR517A	574479	upregulated	resveratrol results in increased expression of MIR517A mRNA	19q13.42	A23973
Resveratrol	Investigational	MIR518B	574474	upregulated	resveratrol results in increased expression of MIR518B mRNA	19q13.42	A23973
Resveratrol	Investigational	MIR518C	574477	upregulated	resveratrol results in increased expression of MIR518C mRNA	19q13.42	A23973
Resveratrol	Investigational	MIR518F	574472	downregulated	resveratrol results in decreased expression of MIR518F mRNA	19q13.42	A23975
Resveratrol	Investigational	MIR519B	574469	upregulated	resveratrol results in increased expression of MIR519B mRNA	19q13.42	A23973
Resveratrol	Investigational	MIR525	574470	upregulated	resveratrol results in increased expression of MIR525 mRNA	19q13.42	A23973
Resveratrol	Investigational	MIR569	693154	upregulated	resveratrol results in increased expression of MIR569 mRNA	3q26.2	A23973
Resveratrol	Investigational	MIR570	693155	upregulated	resveratrol results in increased expression of MIR570 mRNA	3q29	A23973
Resveratrol	Investigational	MIR571	693156	upregulated	resveratrol results in increased expression of MIR571 mRNA	4p16.3	A23973
Resveratrol	Investigational	MIR572	693157	upregulated	resveratrol results in increased expression of MIR572 mRNA	4p15.33	A23974
Resveratrol	Investigational	MIR574	693159	upregulated	resveratrol results in increased expression of MIR574 mRNA	4p14	A23974
Resveratrol	Investigational	MIR576	693161	upregulated	resveratrol results in increased expression of MIR576 mRNA	4q25	A23975
Resveratrol	Investigational	MIR584	693169	upregulated	resveratrol results in increased expression of MIR584 mRNA	5q32	A23973
Resveratrol	Investigational	MIR590	693175	downregulated	resveratrol results in decreased expression of MIR590 mRNA	7q11.23	A23975
Resveratrol	Investigational	MIR601	693186	upregulated	resveratrol results in increased expression of MIR601 mRNA	9q33.3	A23973
Resveratrol	Investigational	MIR615	693200	upregulated	resveratrol results in increased expression of MIR615 mRNA	12q13.13	A23974 A23973
Resveratrol	Investigational	MIR622	693207	upregulated	resveratrol results in increased expression of MIR622 mRNA	13q31.3	A23974 A23973
Resveratrol	Investigational	MIR625	693210	downregulated	resveratrol results in decreased expression of MIR625 mRNA	14q23.3	A23975
Resveratrol	Investigational	MIR629	693214	downregulated	resveratrol results in decreased expression of MIR629 mRNA	15q23	A23974 A23975
Resveratrol	Investigational	MIR631	693216	downregulated	resveratrol results in decreased expression of MIR631 mRNA	15q24.2	A23974
Resveratrol	Investigational	MIR632	693217	upregulated	resveratrol results in increased expression of MIR632 mRNA	17q11.2	A23973

Displaying entries 65351 - 65375 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability